相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients
Diana Moldovan et al.
BIOMARKERS (2015)
Osteoprotegerin Concentrations Relate Independently to Established Cardiovascular Disease in Rheumatoid Arthritis
Raquel Lopez-Mejias et al.
JOURNAL OF RHEUMATOLOGY (2015)
Osteoprotegerin is not a determinant of metabolic syndrome in sub-Saharan Africans after age adjustment
Clarisse Noel Ayina Ayina et al.
ANNALES D ENDOCRINOLOGIE (2014)
Osteoprotegerin Is Associated With Subclinical Left Ventricular Systolic Dysfunction in Diabetic Hypertensive Patients: A Speckle Tracking Study
Ezgi Kalaycioglu et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Fasting insulin sensitivity indices are not better than routine clinical variables at predicting insulin sensitivity among Black Africans: a clamp study in sub-Saharan Africans
Eugene Sobngwi et al.
BMC ENDOCRINE DISORDERS (2014)
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
Mette Bjerre
SPRINGERPLUS (2013)
How can we measure insulin sensitivity/resistance?
B. Antuna-Puente et al.
DIABETES & METABOLISM (2011)
Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
Jong Suk Park et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Osteoprotegerin, vascular calcification and atherosclerosis
Ann Van Campenhout et al.
ATHEROSCLEROSIS (2009)
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice
Sean Morony et al.
CIRCULATION (2008)
Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals:: results from both cross-sectional and interventional study
Marie-Helene Gannage-Yared et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population
Marie-Helene Gannage-Yared et al.
CLINICAL ENDOCRINOLOGY (2006)
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE(-/-) mice
Brian J. Bennett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)